关注
Vahid Heravi Shargh
Vahid Heravi Shargh
The University of Manchester
在 uon.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Antibody-targeted biodegradable nanoparticles for cancer therapy
VH Shargh, H Hondermarck, M Liang
Nanomedicine 11 (1), 63-79, 2016
1192016
Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends
A Badiee, VH Shargh, A Khamesipour, MR Jaafari
Vaccine 31 (5), 735-749, 2013
982013
The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen
A Badiee, A Khamesipour, A Samiei, D Soroush, VH Shargh, MT Kheiri, ...
Experimental parasitology 132 (4), 403-409, 2012
932012
Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA)
H Firouzmand, A Badiee, A Khamesipour, VH Shargh, SH Alavizadeh, ...
Acta tropica 128 (3), 528-535, 2013
632013
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis
VH Shargh, MR Jaafari, A Khamesipour, I Jaafari, SA Jalali, A Abbasi, ...
Vaccine 30 (26), 3957-3964, 2012
612012
Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis
V Heravi Shargh, MR Jaafari, A Khamesipour, SA Jalali, H Firouzmand, ...
Parasitology research 111, 105-114, 2012
472012
Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model
I Jafari, VH Shargh, M Shahryari, A Abbasi, MR Jaafari, A Khamesipour, ...
Immunobiology 223 (6-7), 493-500, 2018
202018
Chemosensitization of temozolomide-resistant pediatric diffuse midline glioma using potent nanoencapsulated forms of a N (3)-propargyl analogue
V Heravi Shargh, J Luckett, K Bouzinab, S Paisey, L Turyanska, ...
ACS Applied Materials & Interfaces 13 (30), 35266-35280, 2021
152021
Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy
VH Shargh, H Hondermarck, M Liang
Nanomedicine (Lond)., 2017
142017
Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
A Askarizadeh, M Mashreghi, E Mirhadi, F Mirzavi, VH Shargh, A Badiee, ...
Cancer nanotechnology 14 (1), 18, 2023
92023
Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion
VH Shargh, H Hondermarck, M Liang
International Journal of Pharmaceutics 515 (1-2), 527-534, 2016
92016
Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer
A Askarizadeh, M Mashreghi, E Mirhadi, A Mehrabian, V Heravi Shargh, ...
Journal of Liposome Research, 1-18, 2023
2023
MULTIFUNCTIONAL NANOMEDICINES BASED ON ALBUMIN FOR TARGETED BREAST CANCER THERAPY
VH Shargh
The University of Newcastle, Australia, 2016
2016
ENHANCING THE EFFICACY OF TYROSINE KINASE INHIBITORS THROUGH BIO-POLYMERIC ALBUMIN HYBRID NANOPARTICLES IN BREAST CANCER
VH Shargh, H Hondermarck, M Liang
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 11, 16-16, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–14